This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Malaysian semiconductors, pharmaceuticals remain exempt from US tariffs, minister says

By Dalila Abu Bakar ( August 1, 2025, 13:18 GMT | Insight) -- Malaysia has emerged from tariff negotiations with the US on relatively strong footing: Its 19 percent rate is roughly in line with most other Southeast Asian countries, the government says it held firm on all of its “red lines” and its key exports — semiconductors and pharmaceuticals — remain exempt from new tariffs. The government says it preserved key domestic policies, despite rejecting US requests for broader market access. In return, Malaysia agreed to streamline import procedures, enhance export controls and make major Boeing aircraft purchases to help narrow its trade deficit.Malaysia has emerged from tariff negotiations with the US on relatively strong footing: Its 19 percent rate is roughly in line with most other Southeast Asian countries, the government says it held firm on all of its “red lines” and its key exports — semiconductors and pharmaceuticals — remain exempt from new tariffs....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections